DUBLIN--(BUSINESS WIRE)--ICON plc (NASDAQ:ICLR), a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today reported its financial results for the fourth quarter and full year ended December 31, 2014.
In the fourth quarter net revenue grew 13.0% year on year to $390.1 million from $345.2 million in the same quarter last year.
Help employers find you! Check out all the jobs and post your resume.
